Loading...

Globus Medical, Inc.

GMEDNYSE
Healthcare
Medical - Devices
$54.48
$1.19(2.23%)

Globus Medical, Inc. (GMED) Stock Overview

Explore Globus Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 75.6/100

Key Financials

Market Cap7.4B
P/E Ratio40.17
EPS (TTM)$1.34
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Week$55.86
1 Month$64.71
3 Months$86.34
1 Year Target$108.64

GMED Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Globus Medical, Inc. (GMED) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $108.64.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 40.17 and a market capitalization of 7.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;